Document Actions
HIV vaccine passes phase 1 trial
The Daily Telegraph reported that a “vaccine could reduce HIV to ‘minor infection’”. The news story reports on a phase I clinical trial that assessed the safety of a new HIV vaccine in a small group of people in Spain.
The researchers recruited 30 people who did not have HIV and gave 24 of them three injections of the new HIV vaccine, which was based on a smallpox vaccine. The other six people received placebo injections. The researchers followed the volunteers for 48 weeks.
